Reading Annual report last nifht, which reconfirms all trial timelines. So by 30th Jund 2019, Immuron will have published trial data on ASH, Pediatric NASH, Cdiff. Then with 3x NASH trial data will partner/commercialise NASH. So could be trading anything between $1-$3 or Nasdaq $IMRN equivalent of $30-$90.
Reading Annual report last nifht, which reconfirms all trial...
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.001(1.00%) |
Mkt cap ! $22.57M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $18.20K | 183.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7820 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 63710 | 4 |
View Market Depth
| Last trade - 15.59pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 9.9¢ | 10.0¢ | 9.8¢ | 42139 | ||
| Last updated 15.59pm 07/05/2024 ? | |||||
| IMC (ASX) Chart |